TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Evel med AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
141
|
136
|
23 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
40
|
63
|
14 |
EBITDA |
40
|
63
|
14 |
Total assets |
108
|
109
|
27 |
Current assets |
108
|
109
|
27 |
Current liabilities |
70
|
53
|
11 |
Equity capital |
38
|
55
|
16 |
- share capital |
5
|
4
|
5 |
Employees (average) |
1
|
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
35.2%
|
50.5%
|
59.3% |
Turnover per employee | 141 | ||
Profit as a percentage of turnover |
28.4%
|
46.3%
|
60.9% |
Return on assets (ROA) |
37.0%
|
57.8%
|
51.9% |
Current ratio |
154.3%
|
205.7%
|
245.5% |
Return on equity (ROE) |
105.3%
|
114.5%
|
87.5% |
Change turnover |
5
|
114
|
23 |
Change turnover % |
4%
|
542% | |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.